373
Views
44
CrossRef citations to date
0
Altmetric
Original Article

Delta‐9-THC based monotherapy in fibromyalgia patients on experimentally induced pain, axon reflex flare, and pain relief

, , , , &
Pages 1269-1276 | Accepted 05 May 2006, Published online: 31 May 2006

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Natalie Strand, Ryan S D’Souza, Jay Karri, Hemant Kalia, Jackie Weisbein, Brian J Kassa, Nasir Hussain, Ahish Chitneni, Ryan R Budwany, Jonathan Hagedorn, Jason E Pope, Timothy R Deer, Dawood Sayed & Alaa Abd-Elsayed. (2023) Medical Cannabis: A Review from the American Society of Pain and Neuroscience. Journal of Pain Research 16, pages 4217-4228.
Read now
Jacob N Ablin & Dan Buskila. (2010) Emerging therapies for fibromyalgia: an update. Expert Opinion on Emerging Drugs 15:3, pages 521-533.
Read now
Ethan B Russo. (2008) Cannabinoids in the management of difficult to treat pain. Therapeutics and Clinical Risk Management 4:1, pages 245-259.
Read now
Jacob N Ablin & Dan Buskila. (2008) Emerging therapies for fibromyalgia. Expert Opinion on Emerging Drugs 13:1, pages 53-62.
Read now
Michael Iskedjian, Basil Bereza, Allan Gordon, Charles Piwko & Thomas R. Einarson. (2007) Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain. Current Medical Research and Opinion 23:1, pages 17-24.
Read now

Articles from other publishers (39)

Claire Wang, Simon Erridge, Carl Holvey, Ross Coomber, Azfer Usmani, Mohammed Sajad, Rahul Guru, Wendy Holden, James J. Rucker, Michael W. Platt & Mikael H. Sodergren. (2023) Assessment of clinical outcomes in patients with fibromyalgia: Analysis from the UK Medical Cannabis Registry. Brain and Behavior 13:7.
Crossref
Horst Bettstetter & Arne Schäfer. (2023) Tetrahydrocannabinol (THC) bei Patienten mit Fibromyalgiesyndrom (FMS)Tetrahydrocannabinol (THC) in patients with fibromyalgia syndrome (FMS). Der Schmerz.
Crossref
Ahmed Hasbi, Bertha K. Madras & Susan R. George. (2023) Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review. Brain Sciences 13:2, pages 325.
Crossref
Rob Velzeboer, Adeeb Malas, Pierre Boerkoel, Katie Cullen, Michelle Hawkins, Jordanna Roesler & Wayne Wei-Ku Lai. (2022) Cannabis dosing and administration for sleep: a systematic review. Sleep 45:11.
Crossref
Renata Ferraz Figueiredo, Alana Teles Costa, Rafaella de Oliveira Santos Silva, Tatiana Damasceno da Silva, Thaciana dos Santos Alcântara, Divaldo Pereira de Lyra Junior & Cristiani Isabel Banderó Walker. (2022) An Overview of the Methodologies and the Quality of Studies on Pharmacotherapy for the Treatment of Fibromyalgia. Current Rheumatology Reviews 18:4, pages 305-316.
Crossref
Hebah Muhsien Sabiah AL Ubeed, Ronald B. H. Wills & Jayani Chandrapala. (2022) Post-Harvest Operations to Generate High-Quality Medicinal Cannabis Products: A Systemic Review. Molecules 27:5, pages 1719.
Crossref
Richard L. Price, Kaarina V. Charlot, Sven Frieler, Joseph R. Dettori, Rod Oskouian & Jens R. Chapman. (2022) The Efficacy of Cannabis in Reducing Back Pain: A Systematic Review. Global Spine Journal 12:2, pages 343-352.
Crossref
Hebah Muhsien Sabiah AL Ubeed, Deep Jyoti Bhuyan, Muhammad A. Alsherbiny, Amrita Basu & Quan V. Vuong. (2022) A Comprehensive Review on the Techniques for Extraction of Bioactive Compounds from Medicinal Cannabis. Molecules 27:3, pages 604.
Crossref
Henry Jair Mayorga Anaya, María Paula Torres Ortiz, Daniel Hernando Flórez Valencia & Omar Fernando Gomezese Ribero. (2021) Efficacy of cannabinoids in fibromyalgia: a literature review. Colombian Journal of Anesthesiology.
Crossref
Inna KurlyandchikEvelin TiralongoJanet Schloss. (2021) Safety and Efficacy of Medicinal Cannabis in the Treatment of Fibromyalgia: A Systematic Review. The Journal of Alternative and Complementary Medicine 27:3, pages 198-213.
Crossref
Massimo E. Maffei. (2020) Fibromyalgia: Recent Advances in Diagnosis, Classification, Pharmacotherapy and Alternative Remedies. International Journal of Molecular Sciences 21:21, pages 7877.
Crossref
Carolina Chaves, Paulo Cesar T Bittencourt & Andreia Pelegrini. (2020) Ingestion of a THC-Rich Cannabis Oil in People with Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Pain Medicine 21:10, pages 2212-2218.
Crossref
Gaurav Gupta, Wafa Hourani, Pran Kishore Deb, Satyendra Deka, Pobitra Borah, Juhi Tiwari, Sacchidanand Pathak & Puneet Kumar. 2020. Frontiers in Pharmacology of Neurotransmitters. Frontiers in Pharmacology of Neurotransmitters 415 445 .
Eric P. Baron, Philippe Lucas, Joshua Eades & Olivia Hogue. (2018) Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort. The Journal of Headache and Pain 19:1.
Crossref
D. Pascual, E.M. Sánchez-Robles, M.M. García & C Goicoechea. (2018) Chronic pain and cannabinoids. Great expectations or a christmas carol. Biochemical Pharmacology 157, pages 33-42.
Crossref
Emily Stockings, Gabrielle Campbell, Wayne D. Hall, Suzanne Nielsen, Dino Zagic, Rakin Rahman, Bridin Murnion, Michael Farrell, Megan Weier & Louisa Degenhardt. (2018) Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies. Pain 159:10, pages 1932-1954.
Crossref
Eric P. Baron. (2018) Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science. Headache: The Journal of Head and Face Pain 58:7, pages 1139-1186.
Crossref
Stevie C. Britch, Jenny L. Wiley, Zhihao Yu, Brian H. Clowers & Rebecca M. Craft. (2017) Cannabidiol-Δ 9 -tetrahydrocannabinol interactions on acute pain and locomotor activity. Drug and Alcohol Dependence 175, pages 187-197.
Crossref
M. Farré, A. Farré, J. Fiz & M. Torrens. 2017. Handbook of Cannabis and Related Pathologies. Handbook of Cannabis and Related Pathologies e158 e167 .
Ethan B. Russo. (2016) Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes. Cannabis and Cannabinoid Research 1:1, pages 154-165.
Crossref
Ernest Small. 2016. Cannabis. Cannabis 229 252 .
Wen-Juan Huang, Wei-Wei Chen & Xia Zhang. (2016) Endocannabinoid system: Role in depression, reward and pain control (Review). Molecular Medicine Reports 14:4, pages 2899-2903.
Crossref
Brian Walitt, Petra Klose, Mary-Ann Fitzcharles, Tudor Phillips & Winfried Häuser. (2016) Cannabinoids for fibromyalgia. Cochrane Database of Systematic Reviews.
Crossref
Mary-Ann Fitzcharles, Peter A. Ste-Marie, Winfried Häuser, Daniel J. Clauw, Shahin Jamal, Jacob Karsh, Tara Landry, Sharon Leclercq, Jason J. Mcdougall, Yoram Shir, Kam Shojania & Zach Walsh. (2016) Efficacy, Tolerability, and Safety of Cannabinoid Treatments in the Rheumatic Diseases: A Systematic Review of Randomized Controlled Trials. Arthritis Care & Research 68:5, pages 681-688.
Crossref
Gunther Landmann, Lenka Stockinger, Corinne Lustenberger, Martin Schmelz & Roman Rukwied. (2016) Effects of Current Density on Nociceptor Activation Upon Electrical Stimulation in Humans. Pain Practice 16:3, pages 273-281.
Crossref
M.-A. Fitzcharles, C. Baerwald, J. Ablin & W. Häuser. (2016) Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome, back pain, osteoarthritis, rheumatoid arthritis)Wirksamkeit, Verträglichkeit und Sicherheit von Cannabinoiden bei chronischen Schmerzen bei rheumatischen Erkrankungen (Fibromyalgiesyndrom, Rückenschmerz, Arthrose, rheumatoide Arthritis): Eine systematische Übersicht von randomisierten kontrollierten Studien. Der Schmerz 30:1, pages 47-61.
Crossref
Eric P. Baron. (2015) Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been …. Headache: The Journal of Head and Face Pain 55:6, pages 885-916.
Crossref
Winfried Häuser, Brian Walitt, Petra Klose & Mary-Ann Fitzcharles. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Javier Fernández-Ruiz, Mariluz Hernández & Yolanda García-Movellán. 2014. Cannabinoids. Cannabinoids 175 218 .
Michael C. Lee, Markus Ploner, Katja Wiech, Ulrike Bingel, Vishvarani Wanigasekera, Jonathan Brooks, David K. Menon & Irene Tracey. (2013) Amygdala activity contributes to the dissociative effect of cannabis on pain perception. Pain 154:1, pages 124-134.
Crossref
Mary-Ann Fitzcharles, Jason McDougall, Peter A. Ste-Marie & Ivan Padjen. (2012) Clinical implications for cannabinoid use in the rheumatic diseases: Potential for help or harm?. Arthritis & Rheumatism 64:8, pages 2417-2425.
Crossref
Peter A. Ste‐Marie, Mary‐Ann Fitzcharles, Ann Gamsa, Mark A. Ware & Yoram Shir. (2012) Association of herbal cannabis use with negative psychosocial parameters in patients with fibromyalgia. Arthritis Care & Research 64:8, pages 1202-1208.
Crossref
A. Benyamina & L. Blecha. (2012) Cannabis et analgésieCannabis and analgesia. Douleur et Analgésie 25:2, pages 78-82.
Crossref
Birgit Kraft. (2012) Is There Any Clinically Relevant Cannabinoid-Induced Analgesia. Pharmacology 89:5-6, pages 237-246.
Crossref
Matthias A. Engel, Iwona Izydorczyk, Sonja M. Mueller-Tribbensee, Christoph Becker, Markus F. Neurath & Peter W. Reeh. (2011) Inhibitory CB1 and activating/desensitizing TRPV1-mediated cannabinoid actions on CGRP release in rodent skin. Neuropeptides 45:3, pages 229-237.
Crossref
Jimena Fiz, Marta Durán, Dolors Capellà, Jordi Carbonell & Magí Farré. (2011) Cannabis Use in Patients with Fibromyalgia: Effect on Symptoms Relief and Health-Related Quality of Life. PLoS ONE 6:4, pages e18440.
Crossref
Matthias Karst, Sonja Wippermann & Jörg Ahrens. (2010) Role of Cannabinoids in the Treatment of Pain and (Painful) Spasticity. Drugs 70:18, pages 2409-2438.
Crossref
John M. McPartland. 2010. Fibromyalgia Syndrome. Fibromyalgia Syndrome 263 277 .
P. Harten. (2007) FibromyalgiesyndromFibromyalgia syndrome. Zeitschrift für Rheumatologie 67:1, pages 75-82.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.